Nordion Ships The First Mo-99 Sample From Russia.

Nordion Inc., a major company providing services and products to healthcare market across the world, announced that the first sample of its Molybdenum-99 (Mo-99) has been shipped from "Isotope", Nordion’s partner in Russia. Mo-99 and other Medical isotopes are used by a wide range of hospitals and healthcare facilities in order to diagnose and treat several medical conditions, such as cardiac and neurological disorders in addition to several forms of cancer.
Back in September, Nordion and Isotope made a supply agreement for Mo-99 that extends until 2020. The recently-shipped sample will be evaluated at Nordion’s facility in Ottawa, Canada. The assessment is taking place in order to get product registration and regulatory approvals before allowing Nordion to start supplying the medical isotope in the Canadian markets.

To read of this news, please visit:

Nordion Ships The First Mo-99 Sample From Russia.